These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 33859643)
21. T cells in the skin: Lymphoma and inflammatory skin disease. Roediger B; Schlapbach C J Allergy Clin Immunol; 2022 Apr; 149(4):1172-1184. PubMed ID: 35247433 [TBL] [Abstract][Full Text] [Related]
22. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. Clinical, histopathologic, and immunohistochemical analyses. Nagatani T; Matsuzaki T; Iemoto G; Kim S; Baba N; Miyamoto H; Nakajima H Cancer; 1990 Dec; 66(11):2380-6. PubMed ID: 2245393 [TBL] [Abstract][Full Text] [Related]
23. Skin-homing CD8+ T lymphocytes show preferential growth in vitro and suppress CD4+ T-cell proliferation in patients with early stages of cutaneous T-cell lymphoma. Thestrup-Pedersen K; Parhar R; Wu K; Bertilsson PA; Meyer B; Abu-Amero S; Hainau B; Aleisa A; Alfadley A; Hamadah I; Alajlan A; Al-Hussein K; Al-Mohanna F Acta Derm Venereol; 2007; 87(2):118-26. PubMed ID: 17340017 [TBL] [Abstract][Full Text] [Related]
24. Histologic and immunophenotypic features prior to transformation in patients with transformed cutaneous T-cell lymphoma: is CD25 expression in skin biopsy samples predictive of large cell transformation in cutaneous T-cell lymphoma? Stefanato CM; Tallini G; Crotty PL Am J Dermatopathol; 1998 Feb; 20(1):1-6. PubMed ID: 9504661 [TBL] [Abstract][Full Text] [Related]
25. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma. Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475 [TBL] [Abstract][Full Text] [Related]
26. Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma. Miyagaki T; Sugaya M; Suga H; Morimura S; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S J Invest Dermatol; 2012 Apr; 132(4):1280-9. PubMed ID: 22297640 [TBL] [Abstract][Full Text] [Related]
28. Application of Blood Lymphocyte Immunophenotype and TCR Gene Rearrangement in the Diagnosis of CTCL. You R; Wang Y; Gong Y; Sun J; Lu Y; Miao L; Guo S; Qu C Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345989 [TBL] [Abstract][Full Text] [Related]
29. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses. Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277 [TBL] [Abstract][Full Text] [Related]
30. Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas. Dommann SN; Dommann-Scherrer CC; Ziegler T; Meyer J; Trüeb RM; Kündig T; Panizzon R; Burg G Am J Dermatopathol; 1997 Aug; 19(4):391-5. PubMed ID: 9261475 [TBL] [Abstract][Full Text] [Related]
31. Detection of clonal T cells in cutaneous T cell lymphoma by polymerase chain reaction: comparison of mutation detection enhancement-polyacrylamide gel electrophoresis, temperature gradient gel electrophoresis and fragment analysis of sequencing gels. Scheller U; Muche JM; Sterry W; Lukowsky A Electrophoresis; 1998 May; 19(5):653-8. PubMed ID: 9629892 [TBL] [Abstract][Full Text] [Related]
32. Interleukin-17 expression in neutrophils and Th17 cells in cutaneous T-cell lymphoma associated with neutrophilic infiltrate of the skin. Fontao L; Brembilla NC; Masouyé I; Kaya G; Prins C; Dupin N; Saurat JH; Chizzolini C; Piguet V Br J Dermatol; 2012 Mar; 166(3):687-9. PubMed ID: 21936854 [No Abstract] [Full Text] [Related]
33. Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome. Shin J; Monti S; Aires DJ; Duvic M; Golub T; Jones DA; Kupper TS Blood; 2007 Oct; 110(8):3015-27. PubMed ID: 17638852 [TBL] [Abstract][Full Text] [Related]
34. Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas. Ni X; Zhang C; Talpur R; Duvic M J Invest Dermatol; 2005 Apr; 124(4):741-50. PubMed ID: 15816832 [TBL] [Abstract][Full Text] [Related]
35. Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation. Geskin LJ; Viragova S; Stolz DB; Fuschiotti P Blood; 2015 Apr; 125(18):2798-805. PubMed ID: 25628470 [TBL] [Abstract][Full Text] [Related]
36. Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma. Kohnken R; Wen J; Mundy-Bosse B; McConnell K; Keiter A; Grinshpun L; Hartlage A; Yano M; McNeil B; Chakravarti N; William B; Bradner JE; Caligiuri MA; Porcu P; Mishra A Blood; 2018 Feb; 131(7):771-781. PubMed ID: 29180399 [TBL] [Abstract][Full Text] [Related]
37. Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma Skin Tumors. Gaydosik AM; Tabib T; Geskin LJ; Bayan CA; Conway JF; Lafyatis R; Fuschiotti P Clin Cancer Res; 2019 Jul; 25(14):4443-4454. PubMed ID: 31010835 [TBL] [Abstract][Full Text] [Related]